Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions
- PMID: 2829753
- DOI: 10.1007/BF00413280
Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions
Abstract
Several biologically active lipoxygenase products or arachidonic acid (AA) have been demonstrated in psoriatic skin lesions. The purpose of the present study was to determine the amounts of the different lipoxygenase products simultaneously in psoriatic skin. Slices of psoriatic skin were obtained at different levels with a keratome. Extracted lipids were identified by high performance liquid chromatography, UV-absorption spectrum, radioimmunoassay, and chemokinesis. Leukotriene B4 (LTB4), and 12- and 15-hydroxy-eicosatetraenoic acid (HETE) were detected in most psoriatic lesions. However, there was a remarkable variation from lesion to lesion. The biopsy specimens contained: 276.2 +/- 126.0 pg/g wet tissue of LTB4, 3,130.0 +/- 2,898.0 ng/g wet tissue of 12-HETE, and 3,633.0 +/- 1,692.0 ng/g wet tissue of 15-HETE. No correlation was found between the levels of the different lipoxygenase products. The content of each of the identified lipoxygenase products was higher in the superficial part of the biopsy specimen consisting of approximately two-thirds of the epidermis plus papillary dermis than in the lower part consisting of approximately one-third of the epidermis plus some reticular dermis. Also, there was a great variation from one anatomical region to another within the same patient. Because these lipoxygenase products possess different biological activities, the variation in their occurrence may be important for understanding their potential role in psoriasis. To determine which lipoxygenase products may be of pathogenic importance, analysis of early psoriatic lesions is warranted.
Similar articles
-
In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.J Invest Dermatol. 1986 Jul;87(1):47-52. doi: 10.1111/1523-1747.ep12523561. J Invest Dermatol. 1986. PMID: 3088130
-
Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.J Invest Dermatol. 1984 Dec;83(6):426-30. doi: 10.1111/1523-1747.ep12273519. J Invest Dermatol. 1984. PMID: 6094672
-
Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.Arch Dermatol. 1986 Aug;122(8):877-80. Arch Dermatol. 1986. PMID: 3090943
-
5-Lipoxygenase activation in psoriasis: a dead issue?Skin Pharmacol. 1993;6(4):292-7. doi: 10.1159/000211152. Skin Pharmacol. 1993. PMID: 8198815 Review.
-
Significance of leukotriene-A4 hydrolase in the pathogenesis of psoriasis.Skin Pharmacol. 1997;10(4):169-77. doi: 10.1159/000211501. Skin Pharmacol. 1997. PMID: 9413890 Review.
Cited by
-
Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.Inflammation. 1995 Apr;19(2):193-205. doi: 10.1007/BF01534461. Inflammation. 1995. PMID: 7601505
-
Effect of auranofin on eicosanoids and protein kinase C in human neutrophils.Agents Actions. 1989 Aug;28(1-2):121-9. doi: 10.1007/BF02022992. Agents Actions. 1989. PMID: 2551149
-
Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology.Front Pharmacol. 2022 Nov 9;13:1042420. doi: 10.3389/fphar.2022.1042420. eCollection 2022. Front Pharmacol. 2022. PMID: 36438817 Free PMC article. Review.
-
Leukotriene B4 and platelet-activating factor in human skin.Arch Dermatol Res. 1992;284 Suppl 1:S12-7. doi: 10.1007/BF00638234. Arch Dermatol Res. 1992. PMID: 1337424 Review.
-
Diversity of mouse lipoxygenases: identification of a subfamily of epidermal isozymes exhibiting a differentiation-dependent mRNA expression pattern.Lipids. 2000 Jul;35(7):701-7. doi: 10.1007/s11745-000-0576-0. Lipids. 2000. PMID: 10941870
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical